当前位置:首页 - 行情中心 - 博雅生物(300294) - 财务分析 - 现金流量表

博雅生物

(300294)

  

流通市值:75.08亿  总市值:75.08亿
流通股本:5.04亿   总股本:5.04亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金694,890,612.44341,454,956.091,795,878,275.021,326,624,834.33
  收到其他与经营活动有关的现金11,728,399.367,656,958.9860,308,940.0236,381,215.24
  经营活动现金流入小计706,619,011.8349,111,915.071,856,187,215.041,363,006,049.57
  购买商品、接受劳务支付的现金338,852,571.08195,691,241.35768,172,040.87556,386,378.2
  支付给职工以及为职工支付的现金217,546,255.75135,041,340.57368,449,075.26290,389,236.5
  支付的各项税费93,246,055.8750,932,713.63183,180,958.57165,421,983.06
  支付其他与经营活动有关的现金193,282,402.5994,675,986.76475,222,452.76324,697,809.93
  经营活动现金流出小计842,927,285.29476,341,282.311,795,024,527.461,336,895,407.69
  经营活动产生的现金流量净额-136,308,273.49-127,229,367.2461,162,687.5826,110,641.88
二、投资活动产生的现金流量:
  收回投资收到的现金2,761,091,453.312,261,091,453.314,975,020,107.174,645,065,066.71
  取得投资收益收到的现金37,353,117.2524,765,666.0155,522,406.7653,758,930.81
  处置固定资产、无形资产和其他长期资产收回的现金净额396,375.39210,148.123,061,389.562,098,306.71
  处置子公司及其他营业单位收到的现金净额26,386,553.48-193,790,119.76158,160,797.81
  投资活动现金流入小计2,825,227,499.432,286,067,267.445,227,394,023.254,859,083,102.04
  购建固定资产、无形资产和其他长期资产支付的现金282,930,449.39187,543,430.76535,308,549.07412,844,043.06
  投资支付的现金2,727,538,463.862,281,000,0005,373,000,0004,810,000,000
  投资活动现金流出小计3,010,468,913.252,468,543,430.765,908,308,549.075,222,844,043.06
  投资活动产生的现金流量净额-185,241,413.82-182,476,163.32-680,914,525.82-363,760,941.02
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,000,0001,000,000
  其中:子公司吸收少数股东投资收到的现金--1,000,0001,000,000
  取得借款收到的现金11,230,00011,230,00047,035,988.71,162,988.7
  筹资活动现金流入小计11,230,00011,230,00048,035,988.72,162,988.7
  分配股利、利润或偿付利息支付的现金37,116,263.41287,796.19156,396,539.61156,317,254.15
  支付其他与筹资活动有关的现金7,041,136.084,137,061.6846,708,824.5644,955,158.66
  筹资活动现金流出小计44,157,399.494,424,857.87203,105,364.17201,272,412.81
  筹资活动产生的现金流量净额-32,927,399.496,805,142.13-155,069,375.47-199,109,424.11
四、汇率变动对现金及现金等价物的影响-208,716.89-104,238.48-133,997.22-57,739.96
五、现金及现金等价物净增加额-354,685,803.69-303,004,626.91-774,955,210.93-536,817,463.21
  加:期初现金及现金等价物余额523,616,179.04523,616,179.041,298,571,389.971,298,571,389.97
  期末现金及现金等价物余额168,930,375.35220,611,552.13523,616,179.04761,753,926.76
补充资料:
  净利润50,884,883.53-112,638,772.02-
  资产减值准备4,877,063.36-316,529,570.79-
  固定资产和投资性房地产折旧42,523,343.15-96,960,872.94-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧42,523,343.15-96,910,547.58-
    投资性房地产折旧--50,325.36-
  无形资产摊销17,616,505.75-49,621,357.38-
  长期待摊费用摊销3,832,647.81-13,040,303.6-
  递延收益摊销--5,880,718.28-
  处置固定资产、无形资产和其他长期资产的损失394,883.47--5,095,324.42-
  固定资产报废损失--1,343,862.03-
  公允价值变动损失-10,444,438.13--59,977,597.95-
  财务费用1,247,412.3--14,541,893.43-
  投资损失34,436,670.69--23,806,314.16-
  递延所得税-53,902,073.9--78,017,575.79-
  其中:递延所得税资产减少-42,392,330.58--9,695,384.51-
    递延所得税负债增加-11,509,743.32--68,322,191.28-
  存货的减少-51,124,930.74--12,597,837.43-
  经营性应收项目的减少-69,409,983.35--471,723,170.76-
  经营性应付项目的增加-110,504,067.17-102,135,210.93-
  不涉及现金收支的投资和筹资活动金额其他项目--11,095,417.78-
  现金的期末余额168,930,375.35-523,616,179.04-
  减:现金的期初余额523,616,179.04-1,298,571,389.97-
  现金及现金等价物的净增加额-354,685,803.69--774,955,210.93-
公告日期2026-08-222026-04-252026-03-212025-10-28
审计意见(境内)标准无保留意见
TOP↑